Revolution Medicines Inc

NASDAQ:RVMD  
25.53
+1.87 (+7.90%)
4:15:41 PM EDT: $25.53 0.00 (0.00%)
Earnings Announcements

Revolution Medicines Reports Third Quarter 2022 Financial Results

Published: 11/07/2022 22:23 GMT
Revolution Medicines Inc (RVMD) - Revolution Medicines Reports Third Quarter 2022 Financial Results and Update on Corporate Progress.
Qtrly Total Revenue Was $3.4 Million.
Reiterating Its Projected Full Year 2022 GAAP Net Loss to Be Between $260 Million and $280 Million.
Qtrly Net Loss per Share $0.87.
Q3 Earnings per Share View $-0.84, Revenue View $6.3 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.34 Million
Adjusted EPS is expected to be -$0.85

Next Quarter Revenue Guidance is expected to be $5.9 Million
Next Quarter EPS Guidance is expected to be -$0.88

More details on our Analysts Page.